Both haemagglutinin-specific antibody and T cell responses induced by a chimpanzee adenoviral vaccine confer protection against influenza H7N9 viral challenge
Abstract Since 2013, the outbreak or sporadic infection of a new reassortant H7N9 influenza virus in China has resulted in hundreds of deaths and thousands of illnesses. An H7N9 vaccine is urgently needed, as a licensed human vaccine against H7N9 influenza is currently not available. Here, we develo...
Guardado en:
Autores principales: | Xiang Wang, Weihui Fu, Songhua Yuan, Xi Yang, Yufeng Song, Lulu Liu, Yudan Chi, Tao Cheng, Man Xing, Yan Zhang, Chao Zhang, Yong Yang, Caihong Zhu, Xiaoyan Zhang, Sidong Xiong, Jianqing Xu, Dongming Zhou |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/01fc40478339433a96e030a84ab2587f |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Rational Zika vaccine design via the modulation of antigen membrane anchors in chimpanzee adenoviral vectors
por: César López-Camacho, et al.
Publicado: (2018) -
Electrostatic Variation of Haemagglutinin as a Hallmark of the Evolution of Avian Influenza Viruses
por: Alireza Heidari, et al.
Publicado: (2018) -
Unique features of a recombinant haemagglutinin influenza vaccine that influence vaccine performance
por: Arun B. Arunachalam, et al.
Publicado: (2021) -
A broadly neutralizing anti-influenza antibody reveals ongoing capacity of haemagglutinin-specific memory B cells to evolve
por: Ying Fu, et al.
Publicado: (2016) -
CRISPR/Cas9 delivery with one single adenoviral vector devoid of all viral genes
por: Eric Ehrke-Schulz, et al.
Publicado: (2017)